Stock PANCHSHEEL PANCHSHEEL ORGANICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Panchsheel Organics Limited

Equities

PANCHSHEEL

INE316G01019

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:53 2024-05-10 am EDT 		5-day change 1st Jan Change
199.2 INR +1.27% Intraday chart for Panchsheel Organics Limited +1.35% +1.63%
Mar. 29 Panchsheel Organics Limited Announces Resignation of Hitesh Singh Parihar as Company Secretary & Compliance Officer CI
Feb. 14 Panchsheel Organics Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 13, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 333.5 336 172 425.8 1,536 2,039
Enterprise Value (EV) 1 386.6 378.9 198.7 420 1,557 2,060
P/E ratio 9.08 x 8.32 x 3.25 x 8.51 x 18.4 x 14.5 x
Yield 1.5% 1.49% - 2.36% 0.98% 1.96%
Capitalization / Revenue 0.79 x 0.69 x 0.34 x 0.86 x 2.22 x 1.98 x
EV / Revenue 0.91 x 0.78 x 0.39 x 0.85 x 2.26 x 2 x
EV / EBITDA 5.55 x 5.28 x 2.28 x 4.84 x 12.1 x 10.3 x
EV / FCF 19.3 x 37.3 x 7.04 x 6.6 x -22.3 x -36.8 x
FCF Yield 5.19% 2.68% 14.2% 15.2% -4.49% -2.72%
Price to Book 1.24 x 1.1 x 0.49 x 1.07 x 3.24 x 2.12 x
Nbr of stocks (in thousands) 10,031 10,031 10,031 10,031 10,031 11,782
Reference price 2 33.25 33.50 17.15 42.45 153.1 173.0
Announcement Date 9/8/18 9/5/19 9/4/20 9/7/21 9/8/22 9/7/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 424 484.7 505 495.6 690.4 1,032
EBITDA 1 69.64 71.79 87 86.74 128.5 199.8
EBIT 1 57.42 60.14 75.88 75.6 116 184
Operating Margin 13.54% 12.41% 15.03% 15.26% 16.8% 17.84%
Earnings before Tax (EBT) 1 51.87 56.58 73.11 72.94 114 190.7
Net income 1 36.74 40.37 52.89 50.06 83.58 140.7
Net margin 8.66% 8.33% 10.47% 10.1% 12.11% 13.64%
EPS 2 3.660 4.025 5.274 4.990 8.330 11.94
Free Cash Flow 1 20.05 10.16 28.22 63.65 -69.91 -55.95
FCF margin 4.73% 2.1% 5.59% 12.84% -10.12% -5.42%
FCF Conversion (EBITDA) 28.79% 14.15% 32.44% 73.38% - -
FCF Conversion (Net income) 54.59% 25.16% 53.36% 127.16% - -
Dividend per Share 2 0.5000 0.5000 - 1.000 1.500 3.400
Announcement Date 9/8/18 9/5/19 9/4/20 9/7/21 9/8/22 9/7/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 53.1 42.9 26.7 - 21.4 21.2
Net Cash position 1 - - - 5.8 - -
Leverage (Debt/EBITDA) 0.7627 x 0.5974 x 0.3068 x - 0.1666 x 0.1059 x
Free Cash Flow 1 20.1 10.2 28.2 63.7 -69.9 -55.9
ROE (net income / shareholders' equity) 14.5% 14.1% 16.1% 13.3% 19.2% 19.6%
ROA (Net income/ Total Assets) 8.59% 8.48% 9.88% 8.61% 11% 11.7%
Assets 1 427.8 475.9 535.4 581.1 759.5 1,202
Book Value Per Share 2 26.90 30.40 35.20 39.60 47.30 81.50
Cash Flow per Share 2 0.3700 0.6000 1.640 4.330 1.970 2.940
Capex 1 7.97 9.99 4.9 17.9 15.3 39.5
Capex / Sales 1.88% 2.06% 0.97% 3.61% 2.22% 3.83%
Announcement Date 9/8/18 9/5/19 9/4/20 9/7/21 9/8/22 9/7/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PANCHSHEEL ORGANICS LIMITED Stock Panchsheel Organics Limited
+1.63% 28.09M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PANCHSHEEL Stock
  4. Financials Panchsheel Organics Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW